Geny Piro

13PUBLICATIONS
41CO-AUTHORS
Molecular targetsPredictive and prognostic markersInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 05, 2024
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance.

A Esposito, A Agostini, G Quero

|Mar 30, 2024
Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms.

Antonio Agostini, Geny Piro, Frediano Inzani

|Feb 10, 2024
The Role of the Complement in Clear Cell Renal Carcinoma (ccRCC)-What Future Prospects Are There for Its Use in Clinical Practice?

Martina Panebianco, Chiara Ciccarese, Alessandro Strusi

|Oct 14, 2022
Immunogenic Cell Death: An Emerging Target in Gastrointestinal Cancers.

Marta Chiaravalli, Alexia Spring, Antonio Agostini

|Sep 14, 2022
Generation and <i>in vivo</i> validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibody.

Lisa Nadal, Frederik Peissert, Abdullah Elsayed

|Jun 25, 2021
Molecular alterations in basal cell carcinoma subtypes.

Lucia Di Nardo, Cristina Pellegrini, Alessandro Di Stefani

Pageof 3

Frequent Collaborators

7 joint publications

Carmine Carbone

4 joint publications

Vincenzo Corbo

3 joint publications

Giampaolo Tortora

2 joint publications

Davide Melisi